Literature DB >> 22318485

On the Mechanism of T cell receptor down-modulation and its physiological significance.

David Escors1, Christopher Bricogne, Frederick Arce, Grazyna Kochan, Katarzyna Karwacz.   

Abstract

Effective, long-lasting immune responses largely depend upon T cell reponses. Antigen-specific T lymphocytes are activated and differentiate into effector T cells after antigen presentation by professional antigen presenting cells (APCs). However, T cell responses are tightly regulated to prevent T cell hyperactivation which may end up in autoimmune pathology. One of these regulatory mechanisms is ligand-induced TCR down-modulation, a process by which TCRs are removed from the T cell surface shortly after engagement with their cognate antigenic peptide associated to MHC molecules on the APC. TCR down-modulation is a complicated process. Here we briefly describe the three main models that attempt to clarify this mechanism in the context of T cell activation and function.

Entities:  

Year:  2011        PMID: 22318485      PMCID: PMC3272427     

Source DB:  PubMed          Journal:  J Biosci Med


  38 in total

1.  Triggering the TCR complex causes the downregulation of nonengaged receptors by a signal transduction-dependent mechanism.

Authors:  E San José; A Borroto; F Niedergang; A Alcover; B Alarcón
Journal:  Immunity       Date:  2000-02       Impact factor: 31.745

2.  T-cell tolerance or function is determined by combinatorial costimulatory signals.

Authors:  Roza Nurieva; Sunil Thomas; Thang Nguyen; Natalia Martin-Orozco; Ying Wang; Murali-Krishna Kaja; Xue-Zhong Yu; Chen Dong
Journal:  EMBO J       Date:  2006-05-25       Impact factor: 11.598

3.  Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b.

Authors:  K Bachmaier; C Krawczyk; I Kozieradzki; Y Y Kong; T Sasaki; A Oliveira-dos-Santos; S Mariathasan; D Bouchard; A Wakeham; A Itie; J Le; P S Ohashi; I Sarosi; H Nishina; S Lipkowitz; J M Penninger
Journal:  Nature       Date:  2000-01-13       Impact factor: 49.962

4.  Program death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemia.

Authors:  Qing Zhou; Meghan E Munger; Steven L Highfill; Jakub Tolar; Brenda J Weigel; Megan Riddle; Arlene H Sharpe; Daniel A Vallera; Miyuki Azuma; Bruce L Levine; Carl H June; William J Murphy; David H Munn; Bruce R Blazar
Journal:  Blood       Date:  2010-06-22       Impact factor: 22.113

5.  Combination of lentivector immunization and low-dose chemotherapy or PD-1/PD-L1 blocking primes self-reactive T cells and induces anti-tumor immunity.

Authors:  Sophie R Sierro; Alena Donda; Rachel Perret; Philippe Guillaume; Hideo Yagita; Frédéric Levy; Pedro Romero
Journal:  Eur J Immunol       Date:  2011-05-27       Impact factor: 5.532

6.  Blockade of programmed death ligand 1 enhances the therapeutic efficacy of combination immunotherapy against melanoma.

Authors:  Shari Pilon-Thomas; Amy Mackay; Nasreen Vohra; James J Mulé
Journal:  J Immunol       Date:  2010-03-01       Impact factor: 5.422

7.  PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors.

Authors:  Michael A Curran; Welby Montalvo; Hideo Yagita; James P Allison
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-16       Impact factor: 11.205

8.  The phosphorylation state of CD3gamma influences T cell responsiveness and controls T cell receptor cycling.

Authors:  J Dietrich; T Bäckström; J P Lauritsen; J Kastrup; M D Christensen; F von Bülow; E Palmer; C Geisler
Journal:  J Biol Chem       Date:  1998-09-11       Impact factor: 5.157

9.  De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling.

Authors:  Ingrid E Wertz; Karen M O'Rourke; Honglin Zhou; Michael Eby; L Aravind; Somasekar Seshagiri; Ping Wu; Christian Wiesmann; Rohan Baker; David L Boone; Averil Ma; Eugene V Koonin; Vishva M Dixit
Journal:  Nature       Date:  2004-07-18       Impact factor: 49.962

10.  Serial triggering of many T-cell receptors by a few peptide-MHC complexes.

Authors:  S Valitutti; S Müller; M Cella; E Padovan; A Lanzavecchia
Journal:  Nature       Date:  1995-05-11       Impact factor: 49.962

View more
  8 in total

1.  Response to Programmed Cell Death-1 Blockade in a Murine Melanoma Syngeneic Model Requires Costimulation, CD4, and CD8 T Cells.

Authors:  Blanca Homet Moreno; Jesse M Zaretsky; Angel Garcia-Diaz; Jennifer Tsoi; Giulia Parisi; Lidia Robert; Katrina Meeth; Abibatou Ndoye; Marcus Bosenberg; Ashani T Weeraratna; Thomas G Graeber; Begoña Comin-Anduix; Siwen Hu-Lieskovan; Antoni Ribas
Journal:  Cancer Immunol Res       Date:  2016-09-02       Impact factor: 11.151

2.  Tumor Antigen and Receptor Densities Regulate Efficacy of a Chimeric Antigen Receptor Targeting Anaplastic Lymphoma Kinase.

Authors:  Alec J Walker; Robbie G Majzner; Ling Zhang; Kelsey Wanhainen; Adrienne H Long; Sang M Nguyen; Paola Lopomo; Marc Vigny; Terry J Fry; Rimas J Orentas; Crystal L Mackall
Journal:  Mol Ther       Date:  2017-07-01       Impact factor: 11.454

3.  Tumour immunogenicity, antigen presentation and immunological barriers in cancer immunotherapy.

Authors:  David Escors
Journal:  New J Sci       Date:  2014-01-05

4.  In-Depth Profiling of T-Cell Responsiveness to Commonly Recognized CMV Antigens in Older People Reveals Important Sex Differences.

Authors:  Bernhard Reus; Stefano Caserta; Martin Larsen; George Morrow; Aalia Bano; Michael Hallensleben; Chakravarthi Rajkumar; Alejandra Pera; Florian Kern
Journal:  Front Immunol       Date:  2021-08-13       Impact factor: 7.561

5.  MODULATING CO-STIMULATION DURING ANTIGEN PRESENTATION TO ENHANCE CANCER IMMUNOTHERAPY.

Authors:  Therese Liechtenstein; Ines Dufait; Alessio Lanna; Karine Breckpot; David Escors
Journal:  Immunol Endocr Metab Agents Med Chem       Date:  2012-09

6.  PD-L1/PD-1 Co-Stimulation, a Brake for T cell Activation and a T cell Differentiation Signal.

Authors:  Therese Liechtenstein; Ines Dufait; Christopher Bricogne; Alessio Lanna; Joeri Pen; Karine Breckpot; David Escors
Journal:  J Clin Cell Immunol       Date:  2012-10-30

7.  Tumor Extracellular Matrix Stiffness Promptly Modulates the Phenotype and Gene Expression of Infiltrating T Lymphocytes.

Authors:  Maila Chirivì; Fabio Maiullari; Marika Milan; Dario Presutti; Chiara Cordiglieri; Mariacristina Crosti; Maria Lucia Sarnicola; Andrea Soluri; Marina Volpi; Wojciech Święszkowski; Daniele Prati; Marta Rizzi; Marco Costantini; Dror Seliktar; Chiara Parisi; Claudia Bearzi; Roberto Rizzi
Journal:  Int J Mol Sci       Date:  2021-05-30       Impact factor: 5.923

8.  Retroviral and lentiviral vectors for the induction of immunological tolerance.

Authors:  Inès Dufait; Therese Liechtenstein; Alessio Lanna; Christopher Bricogne; Roberta Laranga; Antonella Padella; Karine Breckpot; David Escors
Journal:  Scientifica (Cairo)       Date:  2012-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.